Risk of death from breast cancer higher among older patients

February 7, 2012

Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer, according to a study in the February 8 issue of JAMA.

"Breast cancer is the leading contributor to cancer incidence and in women worldwide, with 1,383,500 new cases in 2008. In the United States in 2008, 41 percent of these women were aged 65 years or older at diagnosis. Because breast cancer incidence increases with increasing age, changing demographics and continuously increasing will further enlarge the number of older women confronted with breast cancer," according to background information in the article. "In addition to classic tumor-related prognostic factors, patient characteristics may be associated with breast cancer outcome."

Willemien van de Water, M.D., of the Leiden University Medical Center, Leiden, the Netherlands, and colleagues conducted a study to assess disease-specific mortality among in postmenopausal patients with hormone receptor-positive breast cancer. The study consisted of an analysis of 9,766 patients enrolled in the TEAM ( Adjuvant Multinational) between January 2001 and January 2006. Age at diagnosis was categorized as younger than 65 years (n = 5,349), 65 to 74 years (n = 3,060), and 75 years or older (n = 1,357).

During median (midpoint) follow-up of approximately 5.1 years, there were a total of 1,043 deaths. The number of deaths was 391 (7.3 percent) in patients younger than 65 years, 341(11.2 percent) in patients ages 65 to 74 years, and 311 (22.9 percent) in patients ages 75 years or older. Cumulative incidence of death due to breast cancer increased from 5.7 percent in patients younger than 65 years, 6.3 percent in patients 65 to 74 years of age, to 8.3 percent in patients 75 years or older.

Increasing age was associated with a lower number of deaths due to breast cancer as a proportion of all-cause mortality (less than 65 years, 77.5 percent; 65-74 years, 56.3 percent; 75 years or older, 36.3 percent). Additional analysis indicated that compared with patients younger than 65 years, disease-specific mortality increased with age for patients ages 65 to 74 years and patients 75 years or older.

The researchers also found that mortality from other causes increased with age, and that increasing age was associated with a higher risk of breast cancer relapse.

The authors speculate that a possible underlying mechanism that may help explain the age-specific outcome in this relatively healthy population is that older patients may experience undertreatment, and in particular undertreatment of either chemotherapy or radiotherapy.

"In conclusion, regardless of a higher risk of other-cause mortality and independent of tumor and treatment characteristics, disease-specific mortality increases with age among with hormone receptor-positive breast cancer. These data underline the need for age-specific breast cancer studies in order to improve breast cancer outcome in patients of all ages. Moreover, future detailed population-based and translational studies may increase insight into causal factors of higher disease-specific mortality and relapse with increasing age," the researchers write.

Explore further: Higher incidence of secondary breast cancer seen among black women regardless of age

More information: JAMA. 2012;307[6]:590-597.

Related Stories

Higher incidence of secondary breast cancer seen among black women regardless of age

September 19, 2011
The overall incidence of breast cancer is generally higher among white women than black women; however, the incidence of a second breast cancer in the opposite breast is higher among black women, according to a study presented ...

Adjuvant therapy perhaps not necessary for older breast cancer patients

August 31, 2011
Breast cancer patients over the age of 60 with early-stage, hormone-responsive small tumors who forego adjuvant endocrine, also called hormonal therapy, are not at an increased risk of mortality compared to women of the same ...

Advanced age should not deter women from breast reconstruction after cancer

December 6, 2011
Breast cancer is on the rise and 48 percent of all breast cancers occur in women older than 65, but very few of them choose to have breast reconstruction.

Study finds advances in breast cancer don't extend to older women

November 7, 2011
The survival rates for older women with breast cancer lag behind younger women diagnosed with the disease, indicating that the elder population may be missing out on improvements in treatment and detection, according to new ...

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.